Dasania 50MG (Dasatinib (50mg))

Dasania 50MG contains Dasatinib, a medication primarily used in the treatment of certain types of blood cancers, including chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL). It helps support patients by targeting specific proteins in cancer cells, thereby inhibiting their growth and helping manage the disease. This targeted approach can be beneficial for patients who need a treatment plan tailored to their specific health needs.

The active ingredient, Dasatinib, works by blocking signals that encourage the growth of cancer cells. By interfering with these processes at a cellular level, it aims to reduce the number of cancer cells in the body and improve overall patient outcomes.

For optimal effectiveness, Dasania should be stored at room temperature, away from moisture and direct sunlight. It is important to maintain a consistent schedule when taking this medication, as well as to follow any instructions provided by a healthcare professional. Patients should also be aware of potential interactions with other medications and should communicate any changes in their health to their doctor.

Common, mild side effects may include headache, fatigue, nausea, and diarrhea. While these effects are usually not severe, it is important to discuss any persistent or bothersome symptoms with a healthcare provider.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.